Why is the Inhibition of the Renin-Angiotensin System Effective for Preventing Cardiac Events in Patients with Coronary Risk Factors or Coronary Artery Disease?

By  

Current Cardiology Reviews, Vol. 2, Iss. 4, 2006-11 ,pp. : 293-316

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the west of Scotland coronary prevention study

By Satar N.   Gaw A.   Scherbakova O.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 26-26

Elsevier

Access to resources Recommend Favorite

HIV, Metabolic Syndrome X, Inflammation, Oxidative Stress, and Coronary Heart Disease Risk : Role of Protease Inhibitor Exposure

By Hurwitz Barry E.   Klimas Nancy G.   Llabre Maria M.   Maher Kevin J.   Skyler Jay S.   Bilsker Martin S.   McPherson-Baker Shvawn   Lawrence Peter J.   LaPerriere Arthur R.   Greeson Jeffrey M.   Klaus Johanna R.   Lawrence Rasha   Schneiderman Neil  

Cardiovascular Toxicology, Vol. 4, Iss. 3, 2004-08 ,pp. : 303-316

Humana Press, Inc

Access to resources Recommend Favorite

The metabolic basis for the effects of HRT on coronary heart disease

By Stevenson John  

Endocrine Journal, Vol. 24, Iss. 3, 2004-08 ,pp. : 239-243

Humana Press, Inc

Access to resources Recommend Favorite

Metabolic Syndrome in Adults With Congenital Heart Disease

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 2, 2016-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite